211 related articles for article (PubMed ID: 14621970)
1. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
2. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
3. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
Saleem IY; Smyth HD
Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
[TBL] [Abstract][Full Text] [Related]
4. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
5. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
6. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
7. Moisture uptake and its influence on pressurized metered-dose inhalers.
Williams RO; Hu C
Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Cripps A; Riebe M; Schulze M; Woodhouse R
Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
[TBL] [Abstract][Full Text] [Related]
9. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
10. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
Pu Y; Kline LC; Berry J
Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
[TBL] [Abstract][Full Text] [Related]
11. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
[TBL] [Abstract][Full Text] [Related]
12. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
13. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
Smyth HD; Beck VP; Williams D; Hickey AJ
AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
15. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
Ju D; Shrimpton J; Hearn A
Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
[TBL] [Abstract][Full Text] [Related]
16. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Murnane D; Martin GP; Marriott C
Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
[TBL] [Abstract][Full Text] [Related]
17. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
18. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
McCabe JC; Koppenhagen F; Blair J; Zeng XM
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
[TBL] [Abstract][Full Text] [Related]
19. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
[TBL] [Abstract][Full Text] [Related]
20. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]